USRE36032E - Rice dextrin oral rehydration solution - Google Patents
Rice dextrin oral rehydration solution Download PDFInfo
- Publication number
- USRE36032E USRE36032E US08/071,833 US7183393A USRE36032E US RE36032 E USRE36032 E US RE36032E US 7183393 A US7183393 A US 7183393A US RE36032 E USRE36032 E US RE36032E
- Authority
- US
- United States
- Prior art keywords
- glucose
- iaddend
- iadd
- rice
- short chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 176
- 235000009566 rice Nutrition 0.000 title claims abstract description 176
- 229920001353 Dextrin Polymers 0.000 title claims abstract description 125
- 239000004375 Dextrin Substances 0.000 title claims abstract description 125
- 235000019425 dextrin Nutrition 0.000 title claims abstract description 125
- 239000000310 rehydration solution Substances 0.000 title claims abstract description 34
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 175
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 150
- 239000008103 glucose Substances 0.000 claims abstract description 150
- 229920000642 polymer Polymers 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 38
- 238000001914 filtration Methods 0.000 claims abstract description 25
- 235000013312 flour Nutrition 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 206010012735 Diarrhoea Diseases 0.000 claims abstract description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000008569 process Effects 0.000 claims abstract description 15
- 239000003792 electrolyte Substances 0.000 claims abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 39
- 235000014633 carbohydrates Nutrition 0.000 claims description 39
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 34
- 230000018044 dehydration Effects 0.000 claims description 17
- 238000006297 dehydration reaction Methods 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 14
- 230000036571 hydration Effects 0.000 claims description 10
- 238000006703 hydration reaction Methods 0.000 claims description 10
- 238000012423 maintenance Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 5
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 abstract description 39
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 abstract description 25
- 208000019902 chronic diarrheal disease Diseases 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 description 23
- 102000016679 alpha-Glucosidases Human genes 0.000 description 23
- 239000011734 sodium Substances 0.000 description 23
- 108010065511 Amylases Proteins 0.000 description 21
- 102000013142 Amylases Human genes 0.000 description 21
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 21
- 229910052708 sodium Inorganic materials 0.000 description 21
- 235000019418 amylase Nutrition 0.000 description 19
- 239000004382 Amylase Substances 0.000 description 18
- 230000029087 digestion Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 208000005156 Dehydration Diseases 0.000 description 15
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 13
- 229960003975 potassium Drugs 0.000 description 13
- 229910052700 potassium Inorganic materials 0.000 description 13
- 239000011591 potassium Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 239000012530 fluid Substances 0.000 description 11
- 238000011534 incubation Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 238000005352 clarification Methods 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 238000002671 oral rehydration therapy Methods 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 5
- 229920002245 Dextrose equivalent Polymers 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 4
- 102100022624 Glucoamylase Human genes 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 201000009840 acute diarrhea Diseases 0.000 description 3
- 235000021257 carbohydrate digestion Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 239000008151 electrolyte solution Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 235000021023 sodium intake Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 238000008458 Glucose Oxidase Reagent Methods 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000037817 intestinal injury Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000009061 membrane transport Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
Definitions
- the . .rice-based.!. ORS .Iadd.made from whole rice .Iaddend.of the foregoing references contained from 3 to 5% rice and had electrolyte levels corresponding to conventional WHO . .formations.!. .Iadd.formulations.Iaddend.. They were prepared as follows.
- Still another object of the invention is to provide an improved . .rice based.!. ORS .Iadd.and a composition for prevention of dehydration or maintenance of hydration .Iaddend.which results in lower stool output and a better water and potassium balance during the rehydration period.
- ORS refers to oral rehydration solutions as well as to solutions for the prevention of dehydration and maintenance of hydration..Iaddend.
- the present invention concerns an improved oral rehydration solution comprising a mixture of required electrolytes combined with rice dextrin.
- the invention is based on the discovery that ORS rice dextrin functions better than ORS glucose in infants with chronic diarrhea resulting in lower stool output and enhanced water retention.
- Rice dextrin also has a glucose polymer profile which provides more readily available glucose than corn dextrin or rice flour.
- FIG. 1 is a schematic diagram of a process for clarification of rice dextrin in accordance with the invention.
- the oral rehydration solution of the invention is made by preparing a solution of potassium, sodium, chloride and a base (acetate, lactate, citrate, or bicarbonate) in water.
- Clarified rice dextrin along with optional flavoring agents are added to the solution which is standardized with purified water to provide from 10 to 80 g/l and preferably 10-35 g/L of rice dextrin.
- .Iadd.Electrically balanced electrolytes are added.
- .Iaddend.Sodium is added at 20-100 mEq/L with a preferred level of from 40-60 mEq/L for formulations for . .treatment of acute dehydration.!.
- Preferred potassium levels are from 20-30 mEq/L with a broad range of 20-100 mEq/L operable.
- the chloride anion is preferably added at 30-80 mEq/L with a broad range of 25-100 mEq/L operable.
- the base selected from the group consisting of acetate, lactate, citrate or bicarbonate is preferably added at a range of 25-40 mEq/L with a broad range of 20-50 mEq/L operable.
- the rice dextrin glucose polymer (GP) profile of the instant ORS has a distribution of short chain glucose polymers consisting of 50 to 90% 2 to 6 glucose units and preferably 55 to 80% and most preferably 65 to 75% (Wt./Wt. basis).
- Rice dextrin suitable for use in the ORS of the invention can be obtained from the solubilized rice starch of Puski et al U.S. Pat. No. 4,830,861 incorporated in entirety herein.
- Puski et al describe a procedure whereby the carbohydrate in rice flour is solubilized by amylase enzymes and separated from insoluble rice protein and carbohydrate by centrifugation. The resulting soluble fraction contains about 98% carbohydrate and less than 1% but more than 0.1% protein.
- This material is not suitable as the carbohydrate component of the instant ORS due to trace amounts of particulate matter and residual protein which contributes to foaming and browning problems during processing and sterilization and the formation of a fine precipitate during storage.Iadd., but nonetheless is therapeutically effective as the glucose source in the ORS of the invention.Iaddend..
- the solubilized rice carbohydrate of Puski et al was clarified by a process comprising the steps of:
- the clarified solution can be spray dried following pH adjustment to 4.0-4.8 and preferably 4.5.
- the clarified rice dextrin of the instant process may be spray dried to provide rice dextrin solids having less than 0.1% protein by weight.
- the first filtration essentially reduces the protein to a level where the product can be sterilized without foaming and browning problems.
- the resulting ORS is not acceptable in that it does not have sufficient clarity to meet the requirement of a clear ORS.Iadd., but is therapecutic effective.Iaddend..
- the results in Table 1 show the improved clarity as a result of the second filtration above 80° C.
- the second filtration at a temperature below 80° C. does not remove the haze or precipitate formed in the sterilized . .ORS.!. .Iadd.rice dextrin solution.Iaddend..
- the criticality of the second filtration temperature on the clarity of . .ORS.!. .Iadd.the rice dextrin solution .Iaddend. is shown in Table 2 where results of a second filtration at high (90° C.) and low (45° C.) temperature .Iadd.in another experiment .Iaddend.are set out.
- rice syrup solids are suitable for the instant invention provided they do not contain more than 0.1% by weight protein or other particulate matter and wherein the glucose polymer (GP) profile of GP2 through GP6 is from 50 to 90%. Those that have more than 0.1% by weight protein or other particulate matter are subjected to the instant clarification process.
- Table 3 sets out the distribution of glucose polymer found in samples of .Iadd.commerically available .Iaddend.rice dextrin (RD) and corn dextrin (CD) with similar dextrose equivalents.
- Rice flour (RF) is also compared.
- the unclarified rice dextrin (RD-1) was opaque and had poor physical properties.
- RD-2, RD-3, RD-4 were very clear syrups.
- the corn dextrin syrup was also clear while the rice flour sample was insoluble and opaque.
- WHO World Health Organization
- ORS oral rehydration solutions
- Both rice dextrin and corn dextrin are composed of glucose polymers derived by partial hydrolysis of the parent starch. Digestion of these glucose polymers (GP) in infants involves enzymatic breakdown to glucose by amylase enzymes such as intestinal glucoamylase. This enzyme is distributed throughout the small intestinal mucosa and tends to be more resistant to intestinal injury brought about by diarrhea. Disaccharides and other low molecular weight glucose polymers found in dextrins are the preferred substrate for glucoamylase.
- Table 4 shows a glucose polymer (GP) distribution for rice dextrin of the instant ORS and a commercially available corn dextrin with a similar dextrose equivalent.
- rice dextrins are preferred substrates over corn dextrins for glucoamylase, the primary digestive enzyme for glucose utilization after episodes of infant diarrhea.
- Table 5 sets out the results of enzymatic hydrolysis of rice and corn dextrin by mucosal homogenates.
- enzymes obtained from saliva, duodenal aspirates and duodenal mucosal homogenates were obtained from several infants and pooled. Five hundred mL of carbohydrate solution were incubated with 100 mL of duodenal homogenate and incubated for 3 hours with mechanical shaking at 37° C. Following incubation, the mixtures were heated at 100° C. for 5 minutes, passed through 4 layers of miilipore filters and analyzed on HPLC. The results were combined into two categories GP (2-4) and GP ⁇ 5. The results are shown in Table 5.
- rice dextrin produces significantly more glucose and low molecular weight GP than corn dextrin.
- the higher molecular weight fraction of rice dextrin decreased faster compared to the high molecular weight fraction of corn dextrin.
- Table 6 sets out results of carbohydrate tolerance studies with sixteen infants with chronic diarrhea. The following procedure was used. The patients were fasted for eight hours and then given two grams per kg of a 10% solution of glucose, rice dextrin or corn dextrin in random order on consecutive mornings. All three of the different carbohydrates were well digested and absorbed.
- Serum glucose response curves established that the mean area under the curve of the rice dextrin was significantly greater than corn dextrin during the first 30 and 60 minutes of the tolerance test (p ⁇ 0.05) but not at 120 minutes.
- results of this study illustrate that rice dextrin has a greater maximal rise of serum glucose, a shorter elapsed time until the serum glucose peaked and a larger area under the serum glucose response curve during the first 30 to 60 minutes of testing than corn dextrin. These results demonstrate that rice dextrin is more rapidly hydrolyzed and absorbed than corn dextrin. Thus, rice dextrin provides more readily available glucose than corn dextrin to enable the rapid uptake of water and sodium from an oral rehydration solution.
- Table 10 sets out a comparison of maltase digestion of rice dextrin (RD) and rice flour (RF).
- the maltase digestions were performed by incubating (37° C.) 30 mg. of RD or RF with 20 Units of maltase in a total volume of 1.0 mL for various lengths of time. Following incubation, samples were placed in a boiling water bath for 5 minutes to inactivate the test enzyme. Digested samples were centrifuged to separate insoluble materials (e.g., RF) and the concentration of free glucose in the supernatant determined colorimetrically with a Trinder glucose oxidase reagent (Sigma Chemical Co., St. Louis, Mo.).
- Table 11 sets out a comparison of the amount of glucose in solutions of RD and RF before and after digestion with human pancreatic amylase and excess maltase further illustrating that RD provides substantially higher levels of glucose than RF in a comparative test period.
- Coupled enzyme digestions consisted of incubating 30 mg of RD or RF with 0.28 Units of amylase for desired times, boiling samples for 5 minutes to inactivate the amylase, and subsequent incubation of mixtures with excess maltase (50 Units) to convert available maltose (GP2) and maltotriose (GP3) to free glucose.
- Digested samples were centrifuged to separate insoluble materials (e.g., RF) and the concentration of free glucose calorimetrically determined.
- the filtrate is prepared for a second filtration by the addition of 2.75 g of filter aid and 8.1 g of carbon powder, American Norit.
- the mixture is heated to 90° C. before being filtered on a Buchner filtration funnel coated with filter aid.
- the resulting filtrate is cooled to 30° C. and the pH is adjusted to 4.0-4.5 with 0.1N HCl. This clear filtrate is used in ORS products.
- the processed carbohydrate solutions are clear and colorless at 20% solids and the protein content is ⁇ 0.1% on a solids basis.
- the liquid product is filled into containers for sterilization.
- the nutrient claims per liter are listed as follows:
- the infants total fluid deficit was determined by multiplying estimated percentage of dehydration by the admission weight.
- infants received the ORS in a volume equivalent to twice the calculated fluid deficit.
- the ORS was given by means of a nasogastric tube.
- the infants were reassessed by clinical examination. If rehydration was not achieved, a volume of rehydration solution was given again, calculated according to the more recent estimate of fluid deficit with intake recorded throughout the period of rehydration.
- Non-parametric data was analyzed by the chi-square test. Continuous data was analyzed by ANOVA or repeated measure analysis of . .varients.!. .Iadd.variants .Iaddend.for treatment differences over time. A level of significance was set at p ⁇ 0.05. Results are expressed as mean ⁇ one standard deviation (SD) unless otherwise indicated.
- Table 12 sets out the composition of the oral rehydration solution used in this study.
- Table 13 illustrates there were no significant differences in the clinical features and nutritional status of the study groups.
- Table 14 sets out results of balance studies for fluid and sodium intake. Both groups of patients were comparable with respect to ORS intake over the study period. Glucose ORS patients received an ORS with higher concentration of sodium. Thus, their net sodium intake was significantly higher than the intake of patients given rice dextrin ORS.
- Table 15 sets out the stool output.
- the mean stool output .Iadd.per period .Iaddend.over the entire study period for .Iadd.the .Iaddend.rice dextrin .Iadd.ORS .Iaddend.group was 49.9 g/kg compared to 65.9 g/kg for the glucose ORS group.
- Stool output of sodium and potassium was significantly lower in the rice dextrin ORS group when compared to the glucose .Iadd.ORS .Iaddend.group during the first six hours of treatment.
- Table 16 sets out the net gut balance calculated by subtracting stool output from net intake.
- Fluid gut balance was significantly greater in the rice dextrin ORS group during the first six hours of the rehydration phase.
- the mean fluid balance for the rice dextrin ORS group was greater (55.2 ⁇ 3.1 mL/kg) than the glucose ORS group (41.4 ⁇ 3.2 mL/kg).
- Potassium gut balance in the rice dextrin ORS group was statistically greater than the glucose ORS group during the first six hours of therapy. Throughout the remaining three time periods of the study there was a trend of greater gut balance in the rice dextrin ORS group compared to the glucose ORS group.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
TABLE 1
______________________________________
Effect of Filtration Temperature
on the Clarity of Carbohydrate
Solutions at Room Temperature and 90-95° C.
Spectrophotometric
Visual Clarity.sup.a
Clarity.sup.a
Filtration (20%, w/w, TS)
(400 nm, 20%, w/w, TS)
Temperature (°C.)
RT 90-95° C.
RT 90-95° C.
______________________________________
40-45 Clear Hazy 0.012 0.385
60-65 Clear Hazy 0.013 0.271
70-75 Clear Hazy 0.020 0.138
80-85 Clear Clear 0.012 0.017
90-95 Clear Clear 0.013 0.015
______________________________________
.sup.a Temperatures refer to the solution temperature at the time of
observation or measurement.
TABLE 2
______________________________________
The Effect of Temperature on the Clarity
of Carbohydrate Solutions Prepared Using
Second Filtration Temperatures of 45° C. or 90° C.
Spectrophotometric
Process Temp./
Visual Clarity
Clarity
Sample Temp. (20%, w/w, TS)
(400 nm, 20%, w/w, TS
______________________________________
45° C. Filtration
RT Clear 0.016
90-95° C..sup.a
Hazy 0.246
Cooled to RT.sup.b
Slight Haze 0.019
90° C. Filtration
RT Clear 0.010
90-95° C..sup.a
Clear 0.015
Cooled to RT.sup.b
Clear 0.014
______________________________________
.sup.a The solution was placed in a bath at 90-95° C. for 20
minutes and immediately examined for clarity.
.sup.b The solution placed in a bath at 90-95° C. was subsequently
placed in a room temperature bath.
TABLE 3
______________________________________
Glucose Polymer (GP) Profiles of
Rice Dextrin (RD), Corn Dextrin (CD)
and Rice Flour (RF) by Weight Percent
Unclarified Production Scale
Polymer.sup.a
RD-1 RD-2 RD-3 RD-4** CD RF
______________________________________
GP1 4.1 9.6 6.0 4.7 7.4 0.0
GP2 11.6 9.8 14.1 13.5 7.7 0.0
GP3 15.0 13.0 16.8 16.8 9.1 0.0
GP4 6.5 7.2 7.1 8.9 7.5 0.0
GP5 19.6 8.9 21.2 16.6 7.6 0.0
GP6 10.2 8.0 6.9 13.6 7.7 0.0
>GP7 32.9 43.4 27.8 25.9 53.0 100
______________________________________
*number designates glucose units
**clinical
TABLE 4
______________________________________
Comparison of Rice GP to Corn GP
Distribution by Weight Percent
Rice GP
Corn GP
______________________________________
glucose (GP1) 3.8 6.2
GP2-GP6 65.7 33.6
>GP6 30.5 60.1
______________________________________
TABLE 5
______________________________________
In Vitro Hydrolysis of Rice and Corn
Dextrins By Pooled Mucosal Homogenates
Glucose GP (2-4)* GP > 5*
______________________________________
rice +.74 ± .19.sup.a
+1.32 ± .21.sup.a
-2.16 ± .16.sup.a
corn +.22 ± .03.sup.b
+0.56 ± .19.sup.b
-0.79 ± .25.sup.b
______________________________________
*glucose units
.sup.a Values having different superscripts are significantly different (
<0.01)
TABLE 6
______________________________________
Maximal Serum Glucose Response and Elapsed Time
Until Peak Serum Glucose Following Oral Consumption
Of Gluocse, Rice Dextrin and Corn Dextrin ORS
Maximal increase in
Elapsed time until
serum glucose
peak serum glucose
mg/Dl (X ± SD)
min (X ± SD)
______________________________________
Glucose 41.1 ± 14.5.sup.a
31.9 ± 7.5.sup.a
Rice Dextrin
36.6 ± 7.3.sup.a
34.0 ± 10.2.sup.a
Corn Dextrin
7.6 ± 10.3.sup.b
52.5 ± 25.7.sup.b
______________________________________
.sup.a Values having different superscripts are significantly different (
<0.02).
TABLE 7
______________________________________
Soluble Solids Content of Clarified
Rice Dextrin, Pop Rice Powder and Rice Flour
at 25° C. Before and After and 80° C. Heat Treatment
Soluble Solids Content (%, w/w)
Temperature (°C.).sup.a
Product 25 (1) 25 (2)
______________________________________
Clarified Rice Dextrin
100 100
Pop Rice Powder 13 20
Rice Flour 4 2
______________________________________
.sup.a The number in parentheses refers to measurements taken before (1)
and after (2) heating to 80° C.
TABLE 8
______________________________________
Spectrophotometric Clarity of Solutions of Rice
Dextrin, Pop Rice Powder and Rice Flour . .Solutions.!.
at 25° C. Before and After an 80° C. Heat Treatment
Spectrophotometric Clarity
(Absorbance, 400 nm)
Temperature (°C.).sup.a
Product 25 (1) 25 (2)
______________________________________
Rice Dextrin 0.002 0.009
Pop Rice powder 3.22 3.23
Rice Flour 2.54 2.73
______________________________________
.sup.a The number in parentheses refers to measurements taken before (1)
and after (2) heating to 80° C.
TABLE 9
______________________________________
Organoleptic Evaluation of Clarified
Rice Dextrin, Pop Rice Powder and Rice Flour
Solutions at 25° C. Before and After 80° C. Heat Treatment
Description
Temperature (°C.).sup.a
Product/Attribute
25 (1) 25 (2)
______________________________________
Clarified Rice Dextrin
Appearance Water-like, clear
Same
solution
Odor Odor free Same
Flavor/mouthfeel
Slight sweet, clean
Same
flavor, water-like
mouthfeel
Pop Rice Powder
Appearance Opaque, tan colored
Same
solution. Sediment,
many dark specks.
Griany appearance on
glass.
Odor Strong wheat flour
Same
odor. Slightly
unpleasant (sulfureous
or wet dog).
Flavor/mouthfeel
Strong wheat flour
Same
flavor. Gritty
mouthfeel, mucilaginous,
throat-clinging.
Rice Flour
Appearance Opaque, white colored
Same
solution. Sediment,
few dark specks. Grainy
appearance on glass.
Odor Mild wheat flour odor.
Same
Flavor/mouthfeel
Mild wheat flour
Mild wheat
flavor. Gritty flour flavor.
mouthfeel Gritty mouth-
feel, mucila-
ginous,
throat-
clinging.
______________________________________
.sup.a The number in parentheses refers to observations taken before (1)
or after (2) heating to 80° C.
TABLE 10
______________________________________
In vitro Hydrolysis of Rice Dextrins
and Rice Flour by Maltase
Maltase Glucose
Incubation Production (mg).sup.a
Substrate (min) Total.sup.b
Adjusted.sup.c
______________________________________
Rice Flour 0 (blank) 0.00 0.00
5 0.03 0.03
10 0.00 0.00
20 0.00 0.00
40 0.03 0.03
Rice Dextrin
0 (blank) 0.85 0.00
5 2.97 2.12
10 3.93 3.08
20 4.91 4.06
40 6.01 5.16
______________________________________
.sup.a Represents the mean of two separate assays using a total of 20
units of maltase and 30 mg of substrate.
.sup.b Represents total glucose detected following incubation of substrat
with maltase.
.sup.c Represents only glucose produced directly as a result of maltase
digestion (i.e., after subtracting free glucose is undigested substrate).
TABLE 11
______________________________________
In vitro Hydrolysis of Rice Dextrins and Rice Flour
with Pancreatic Amylase Followed by a Maltase
Digestion Step to Generate Free Gluocse
Amylase
Incubation
Glucose Production (mg).sup.a
Substrate (min) Total.sup.b
______________________________________
Rice Flour 0 (blank)
0.00
2 1.16
5 2.01
10 3.10
20 5.65
40 8.83
Rice Dextrins
0 (blank)
7.00
2 8.23
5 9.07
10 10.24
20 11.80
40 13.73
______________________________________
.sup.a Represents the mean of two separate assays using a total of 0.28
Units of human pancreatic amylase and 30 mg of substrate.
.sup.b Represents total glucose detected following incubation of substrat
with maltase and amylase.
______________________________________ Claims Per Liter ______________________________________ Sodium mEq. 50 Chloride mEq. 45 Potassium mEq. 25 Citrate mEq. 34 Rice dextrinsg 30 Claories kcal 120 ______________________________________
TABLE 12
______________________________________
Composition of Oral Rehydration Solution
Rice Dextrin
Glucose
______________________________________
Sodium (mmol/L) 50 75
Potassium (mmol/L)
25 20
Chloride (mmol/L) 45 65
Citrate (mmol/L) 10 10
Glucose (g/L) -- 25
Rice Syrup Solids (g/L)
30 --
Osmolality (mOsm/kg)
200 305
______________________________________
TABLE 13
______________________________________
Clinical Features of patients on Entry into the Study
Rice Dextrin
Glucose
Variables (n = 30) (n = 29)
______________________________________
Age, month 9.8 ± 4.1
9.8 ± 4.2
Weight, kg 7.2 ± 1.6
7.8 ± 1.6
Duration of diarrhea, days
2.5 ± 1.5
2.8 ± 1.8
Number of stools/day
12 15
Estimated dehydration
(% patients enrolled)
Mild 19 19
Moderate 17 14
______________________________________
TABLE 14
______________________________________
Fluid and Sodium Intake During Study
Rice Dextrin
Glucose
Variables (n = 30 (n = 29)
______________________________________
Fluid (mL/kg)
0-6 hours 108 ± 9 104 ± 9
0-12 hours 82 ± 6 80 ± 6
0-48 hours 105 ± 7 107 ± 7
Sodium (mmol/kg)
0-6 hour 5.2 ± 0.4
7.6 ± 0.7*
0-12 hours 3.9 ± 0.4
5.4 ± 0.4*
0-48 hours 4.4 ± 0.4
6.5 ± 0.4*
______________________________________
Values represent Mean ± SEM
*Significantly different P <0.05
TABLE 15
______________________________________
Stool Output
Groups
Rice Dextrin
Glucose
Variables (n = 30) (n = 29)
______________________________________
Weight (g/kg)
0-6 hours 28.7 ± 4.1
45.5 ± 6.7*
6-12 hours 29.1 ± 3.6
32.0 ± 6.2
12-24 hours 55.0 ± 5.6
68.5 ± 10.1
24-48 hours 86.7 ± 11.9
117.6 ± 20.5
Na (mmol/kg)
0-6 hours 1.38 ± 0.25
2.88 ± 0.65*
6-12 hours 1.39 ± 0.21
1.90 ± 0.46
12-24 hours 2.39 ± 0.27
4.15 ± 0.67
24-48 hours 4.24 ± 0.70
6.81 ± 1.40
K (mmol/kg)
0-6 hours 1.02 ± 0.14
1.45 ± 0.16*
6-12 hours 0.99 ± 0.13
0.97 ± 0.17
12-24 hours 1.81 ± 0.17
1.83 ± 0.30
24-48 hours 2.75 ± 0.32
3.04 ± 0.66
______________________________________
Values represent Mean ± SEM.
*Statistically different p <0.05
TABLE 16
______________________________________
Net Gut Balance
Groups
Rice Dextrin
Glucose
Variables (n = 30) (n = 29)
______________________________________
Fluid (mL/kg)
0-6 hours 79.4 ± 6.5*
58.6 ± 5.2
6-12 hours 25.6 ± 6.0
24.2 ± 4.1
12-24 hours 46.7 ± 5.6
21.8 ± 4.9
24-48 hours 69.0 ± 7.1
61.3 ± 6.9
Sodium (mmol/kg)
0-6 hours 3.74 ± 0.36
4.75 ± 0.51
6-12 hours 0.95 ± 0.38
1.26 ± 0.22
12-24 hours 1.46 ± 0.36
1.30 ± 0.40
24-48 hours 2.29 ± 0.51
3.04 ± 0.93
Potassium (mmol/kg)
0-6 hours 1.59 ± 0.23*
0.63 ± 0.13
6-12 hours 0.36 ± 0.21
0.22 ± 0.16
12-24 hours 0.42 ± 0.18
0.16 ± 0.21
24-48 hours 1.00 ± 0.26
0.75 ± 0.35
______________________________________
Values represent Mean ± SEM.
*Statistically different p <0.05
Claims (16)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/071,833 USRE36032E (en) | 1990-04-03 | 1993-06-03 | Rice dextrin oral rehydration solution |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/504,142 US5096894A (en) | 1990-04-03 | 1990-04-03 | Rice dextrin oral rehydration solution |
| US08/071,833 USRE36032E (en) | 1990-04-03 | 1993-06-03 | Rice dextrin oral rehydration solution |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/504,142 Reissue US5096894A (en) | 1990-04-03 | 1990-04-03 | Rice dextrin oral rehydration solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE36032E true USRE36032E (en) | 1999-01-05 |
Family
ID=26752707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/071,833 Expired - Lifetime USRE36032E (en) | 1990-04-03 | 1993-06-03 | Rice dextrin oral rehydration solution |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USRE36032E (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6337106B1 (en) | 1999-06-01 | 2002-01-08 | Rohm And Haas | Method of producing a two-pack fast-setting waterborne paint composition and the paint composition therefrom |
| US6475556B1 (en) | 1999-11-25 | 2002-11-05 | Rohm And Haas Company | Method for producing fast drying multi-component waterborne coating compositions |
| US6555615B2 (en) | 2000-03-03 | 2003-04-29 | Rohm And Haas Company | Removable coating composition and preparative method |
| US20090029010A1 (en) * | 2007-07-24 | 2009-01-29 | Ritorna Natural, Inc. | Organic sports drink containing rice syrup and agave nectar |
| US20090029009A1 (en) * | 2007-07-24 | 2009-01-29 | St Phard Dimitri | Sports drink containing rice syrup and agave nectar |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4756912A (en) * | 1986-04-28 | 1988-07-12 | California Natural Products | Rice syrup sweetener production |
| US4830861A (en) * | 1988-07-14 | 1989-05-16 | Bristol-Myers Company | Low manganese high protein rice flour |
| US4876096A (en) * | 1986-04-28 | 1989-10-24 | California Natural Products | Rice syrup sweetener |
| US4942042A (en) * | 1985-05-15 | 1990-07-17 | Societe De Conseils De Recherches Et D'applications Scientifiques (S. C. A. S.) | Anti-diarrhea compositions |
-
1993
- 1993-06-03 US US08/071,833 patent/USRE36032E/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942042A (en) * | 1985-05-15 | 1990-07-17 | Societe De Conseils De Recherches Et D'applications Scientifiques (S. C. A. S.) | Anti-diarrhea compositions |
| US4756912A (en) * | 1986-04-28 | 1988-07-12 | California Natural Products | Rice syrup sweetener production |
| US4876096A (en) * | 1986-04-28 | 1989-10-24 | California Natural Products | Rice syrup sweetener |
| US4830861A (en) * | 1988-07-14 | 1989-05-16 | Bristol-Myers Company | Low manganese high protein rice flour |
Non-Patent Citations (24)
| Title |
|---|
| Carpenter et al., New England Journal of Medicine, 319:1346 1348 (1988). * |
| Carpenter et al., New England Journal of Medicine, 319:1346-1348 (1988). |
| Daum et al., Pediatr. Res., 12: 24 26, 1978, Intestinal Osmolality and Carbohydrate Absorption in Rats Treated with Polymerized Glucose . * |
| Daum et al., Pediatr. Res., 12: 24-26, 1978, "Intestinal Osmolality and Carbohydrate Absorption in Rats Treated with Polymerized Glucose". |
| El Mougi et al. J. of Pediatric Gastroenterology and Nutrition, 7:572 576 (1988). * |
| El Mougi et al. J. of Pediatric Gastroenterology and Nutrition, 7:572-576 (1988). |
| Klish et al., Pediatr. Res., 14 1343 1346, 1980, The Effect of Intestinal Solute Load on Water Secretion in Infants with Acquired Monosaccharide Intolerance . * |
| Klish et al., Pediatr. Res., 14 1343-1346, 1980, "The Effect of Intestinal Solute Load on Water Secretion in Infants with Acquired Monosaccharide Intolerance". |
| Lebenthal et al., J. Pediatrics , 103:29 34 (1983). * |
| Lebenthal et al., J. Pediatrics, 103:29-34 (1983). |
| Lehringer, Albert L. Biochemistry: The Molecular Basis of Cell Structure and Function. Woth Publishers: New York, 1975, pp. 62 63. * |
| Lehringer, Albert L. Biochemistry: The Molecular Basis of Cell Structure and Function. Woth Publishers: New York, 1975, pp. 62-63. |
| Mahalanabis et al., J. Diar. Dis. Res. 1(2):76 81, Jun. 1983, In Search of a Super Oral Rehydration Solution: Can Optimum Use of Organic Solute Mediated Sodium Absorption Lead To The Development Of An Absorption Promoting Drug . * |
| Mahalanabis et al., J. Diar. Dis. Res. 1(2):76-81, Jun. 1983, "In Search of a Super Oral Rehydration Solution: Can Optimum Use of Organic Solute-Mediated Sodium Absorption Lead To The Development Of An Absorption Promoting Drug?". |
| Mauer et al., "Use of Oral Fluid Therapy and Posttreatment Feeding Following Enteritis in Children in a Developed Country", Committee on Nutrition, Pediatrics, vol. 75, No. 2, Feb. 1985. |
| Mauer et al., Use of Oral Fluid Therapy and Posttreatment Feeding Following Enteritis in Children in a Developed Country , Committee on Nutrition, Pediatrics, vol. 75, No. 2, Feb. 1985. * |
| Molla et al. J. of Pediatric Gastroenterology and Nutrition, 8:81 84 (1989). * |
| Molla et al. J. of Pediatric Gastroenterology and Nutrition, 8:81-84 (1989). |
| Molla et al. The Lancet, 1317 1319 (1982). * |
| Molla et al. The Lancet, 1317-1319 (1982). |
| Patra et al. Archives of Disease in Childbood, 57:910 912 (1982). * |
| Patra et al. Archives of Disease in Childbood, 57:910-912 (1982). |
| Sandhu et al., 57, 152 160, 1982, Oral rehydration in acute infantile diarrhoea with a glucose polymer electrolyte solution . * |
| Sandhu et al., 57, 152-160, 1982, "Oral rehydration in acute infantile diarrhoea with a glucose-polymer electrolyte solution". |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6337106B1 (en) | 1999-06-01 | 2002-01-08 | Rohm And Haas | Method of producing a two-pack fast-setting waterborne paint composition and the paint composition therefrom |
| US6475556B1 (en) | 1999-11-25 | 2002-11-05 | Rohm And Haas Company | Method for producing fast drying multi-component waterborne coating compositions |
| US6555615B2 (en) | 2000-03-03 | 2003-04-29 | Rohm And Haas Company | Removable coating composition and preparative method |
| US20090029010A1 (en) * | 2007-07-24 | 2009-01-29 | Ritorna Natural, Inc. | Organic sports drink containing rice syrup and agave nectar |
| US20090029009A1 (en) * | 2007-07-24 | 2009-01-29 | St Phard Dimitri | Sports drink containing rice syrup and agave nectar |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5096894A (en) | Rice dextrin oral rehydration solution | |
| US5380717A (en) | Food composite for performing function of large bowel regulation | |
| US6774111B1 (en) | Carbohydrate system and a method for providing nutrition to a diabetic | |
| JPH0767368B2 (en) | Formulated milk and its preparation method | |
| KR20010013449A (en) | Food grade starch resistant to alpha-amylase | |
| JP2004161998A (en) | Soluble and highly branched glucose polymer and method for producing the same | |
| JP2004524040A (en) | Mixture of fructose and lactose as low calorie bulk sweetener with reduced glycemic index | |
| JP2001514523A (en) | Nutritional compositions comprising hydrolyzed proteins and fiber blends | |
| US5519011A (en) | Food composite performing function of improving serum lipid | |
| JP2639726B2 (en) | Water-soluble dietary fiber and method for producing the same | |
| US5489440A (en) | Rice flour-based oral rehydration solution | |
| CA2547934A1 (en) | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion | |
| USRE36032E (en) | Rice dextrin oral rehydration solution | |
| Morita et al. | Physiological functions of resistant proteins: proteins and peptides regulating large bowel fermentation of indigestible polysaccharide | |
| EP0535627B1 (en) | Alcoholic beverage containing an indigestible dextrin | |
| JPH0965836A (en) | α-Glucosidase inhibitor, sugar composition containing the same, sweetener, food and feed | |
| US5120539A (en) | Amylase-electrolyte oral rehydration method and composition | |
| JP3641284B2 (en) | Glucose tolerance disorder improving agent | |
| EP2027862B1 (en) | Composition for enhancing immune function comprising zinc and a nigerooligosaccharide | |
| US5523086A (en) | Method for manufacturing a health food utilizing a garlic | |
| FR3100107A1 (en) | Preparation for thickening the food bolus | |
| JPH11137236A (en) | Novel type of refined sake and it production | |
| Carman et al. | The Nutritive Value of Cereal Breakfast Foods: II. Digestibility in Vitro, with a Study of Methods | |
| JP2002369658A (en) | Pet food | |
| Fernandes | Hepatic glycogenosis: diagnosis and management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |
|
| AS | Assignment |
Owner name: VERNER, JOHN V., JR., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TOURNEASE, INC.;REEL/FRAME:022037/0916 Effective date: 20081226 |
|
| AS | Assignment |
Owner name: MJN RESTRUCTURING HOLDCO, INC.,INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISTOL-MYERS SQUIBB COMPANY;REEL/FRAME:022248/0663 Effective date: 20090130 Owner name: MJN RESTRUCTURING HOLDCO, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISTOL-MYERS SQUIBB COMPANY;REEL/FRAME:022248/0663 Effective date: 20090130 |
|
| AS | Assignment |
Owner name: MEAD JOHNSON NUTRITION COMPANY,INDIANA Free format text: MERGER;ASSIGNOR:MJN RESTRUCTURING HOLDCO, INC.;REEL/FRAME:022354/0768 Effective date: 20090204 Owner name: MEAD JOHNSON NUTRITION COMPANY, INDIANA Free format text: MERGER;ASSIGNOR:MJN RESTRUCTURING HOLDCO, INC.;REEL/FRAME:022354/0768 Effective date: 20090204 |
|
| AS | Assignment |
Owner name: BRISTOL-MYERS SQUIBB COMPANY, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAO, MICHAEL C.;LITOV, RICHARD E.;EUBER, JOHN R.;AND OTHERS;REEL/FRAME:022542/0581;SIGNING DATES FROM 19900425 TO 19900501 |